Classification and pathology of gastroenteropancreatic neuroendocrine neoplasms

  1. Günter Klöppel
  1. Department of Pathology, Technical University of München, Ismaninger Strasse 22, 81675 München, Germany
  1. (Correspondence should be addressed to G Klöppel; Email: guenter.kloeppel{at}alumni.uni-kiel.de)
  1. Figure 1

    (a) Well-differentiated neuroendocrine tumour. (b) Poorly differentiated neuroendocrine carcinoma.

  2. Figure 2

    Well-differentiated neuroendocrine neoplasms of the stomach: (a) multiple small polypoid tumours in the corpus region of the stomach associated with chronic atrophic gastritis of the oxyntic mucosa (type 1 gastric NET). (b) ECL cell hyperplasia in the oxyntic mucosa with microtumours. (c) ECL cell hyperplasia in patients with MEN1. (d) Type 3 NEN of the stomach with infiltration of muscular wall.

  3. Figure 3

    Relative ratios of neuroendocrine tumours of the duodenum defined by their hormone expression. Neuroendocrine tumour archives of the Department of Pathology, University of Kiel, 1970 and 2006. Reproduced with kind permission from Springer Science+Media: Virchows Archiv, Site-specific biology and pathology of gastroenteropancreatic neuroendocrine tumors, volume 451 supplement 1, ppS9–S27, Klöppel et al. (2007).

  4. Figure 4

    Well-differentiated neuroendocrine tumour of the duodenum producing gastrin. Duodenal mucosa showing a small submucosal tumour.

  5. Figure 5

    Gangliocytic paraganglioma showing triphasic cellular differentiation: Ganglion cells (center), endocrine cells (left) and Schwann cells (right).

  6. Figure 6

    (a) Small neuroendocrine carcinomas (arrows) of the ileum with large lymph node metastasis in the mesenterium. (b) The tumour infiltrates the muscular layer and produces serotonin.

  7. Figure 7

    Well-differentiated serotonin-producing neuroendocrine carcinoma of the appendix with infiltration of the mesoappendix and angioinvasion.

  8. Figure 8

    Pancreatic neuroendocrine tumours: (a) tumour with a diameter of 2 cm (insulinoma without metastases), (b) large malignant tumour (>2 cm) in the head of the pancreas (malignant insulinoma with metastases). Reproduced with kind permission from Springer Science+Media: Virchows Archiv, Site-specific biology and pathology of gastroenteropancreatic neuroendocrine tumors, volume 451 supplement 1, ppS9–S27, Klöppel et al. (2007).

  9. Figure 9

    Insulinomatosis of the pancreas showing multiple microtumours staining for insulin.

| Table of Contents